Financial Data and Key Metrics Changes - In Q4 2025, revenue reached $304 million, growing 24% year-over-year and 12% organically, with full-year revenue increasing 17% to $1.1 billion [21][22] - Adjusted EBITDA for Q4 was $129 million, up 29% year-over-year, with an adjusted EBITDA margin of 42.5%, exceeding the long-term target of 40% [10][24] - Unlevered free cash flow was $80 million in Q4 and $365 million for the full year, converting 79% of adjusted EBITDA to unlevered free cash flow [25] Business Line Data and Key Metrics Changes - Subscription revenue for Q4 was $168 million, increasing 38% year-over-year, while volume-based revenue was $134 million, up 11% year-over-year [23] - For the full year, subscription revenue totaled $558 million, a 22% increase, and volume-based revenue reached $535 million, also up 11% year-over-year [24] Market Data and Key Metrics Changes - Waystar added 85 clients with trailing twelve-month spend above $100,000 in Q4, up from 30 a year ago, indicating strong market demand [9] - The company achieved a Net Revenue Retention rate of 112% and a Gross Revenue Retention rate of 97% [9][22] Company Strategy and Development Direction - The acquisition of Iodine Software expanded Waystar's addressable market and client base, adding over 1,000 hospitals and health systems [7][11] - Waystar aims to lead in AI-powered revenue cycle automation, with approximately 50% of its solutions leveraging AI [14][20] - The company is focused on delivering a fully autonomous revenue cycle, integrating clinical and financial data to enhance operational efficiency [12][87] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the durability of the business model, anticipating continued low double-digit revenue growth [10][26] - The company expects revenue for 2026 to be between $1.274 billion and $1.294 billion, representing a 17% year-over-year growth [26][28] - Management highlighted strong customer confidence and a robust sales pipeline entering 2026 [10][27] Other Important Information - Waystar's partnership with Google Cloud's Gemini LLM is expected to accelerate innovation in AI capabilities [16] - The company is committed to maintaining a leverage ratio at or below 3x and continuing to reinvest in growth opportunities [25][29] Q&A Session Summary Question: AI and customer appetite for LLMs - Management noted that most clients prefer integrating AI capabilities into existing systems rather than building their own, highlighting a trend towards trusted partnerships in AI deployment [31][41] Question: New AI agents and revenue opportunities - New AI agents are expected to provide both incremental revenue opportunities and enhance the existing AI offerings, contributing to client retention and value [42][44] Question: Cost structure and margin guidance - The increase in G&A, R&D, and SG&A costs is attributed to the inclusion of Iodine, with expectations for continued margin improvement through cost synergies [47][49] Question: AI market growth in healthcare - Management sees significant opportunities in AI within healthcare, emphasizing the need for secure, scalable, and accurate solutions [60][62] Question: Patient utilization assumptions for 2026 - Management expects patient utilization to remain healthy, aligning with historical trends and supporting revenue growth [66] Question: Impact of high-deductible health plans on patient volumes - There was a sequential decrease in patient volumes as patients met their deductibles, but this was offset by growth in provider solutions [70][72] Question: Competitive landscape and ROI - Management emphasized the compelling ROI of their platform compared to point solutions, noting strong win rates and client preference for integrated solutions [83][84]

Financial Data and Key Metrics Changes - In Q4 2025, revenue reached $304 million, growing 24% year-over-year and 12% organically, with full-year revenue increasing 17% to $1.1 billion [21][22] - Adjusted EBITDA for Q4 was $129 million, up 29% year-over-year, with an adjusted EBITDA margin of 42.5%, exceeding the long-term target of 40% [10][24] - Unlevered free cash flow was $80 million in Q4 and $365 million for the full year, converting 79% of adjusted EBITDA to unlevered free cash flow [25] Business Line Data and Key Metrics Changes - Subscription revenue for Q4 was $168 million, increasing 38% year-over-year, while volume-based revenue was $134 million, up 11% year-over-year [23] - For the full year, subscription revenue totaled $558 million, a 22% increase, and volume-based revenue reached $535 million, also up 11% year-over-year [24] Market Data and Key Metrics Changes - Waystar added 85 clients with trailing twelve-month spend above $100,000 in Q4, a 16% year-over-year increase, with a net revenue retention rate of 112% [9][22] - The company processed over 7 billion transactions annually, touching approximately 60% of the U.S. patient population each year [17] Company Strategy and Development Direction - The acquisition of Iodine Software expanded Waystar's addressable market and client base, adding over 1,000 hospitals and health systems [7][11] - Waystar aims to lead in AI-powered revenue cycle automation, with approximately 50% of its solutions leveraging AI [14][20] - The company is focused on delivering a fully autonomous revenue cycle, integrating clinical and financial data to enhance operational efficiency [12][87] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the durability of their business model, expecting normalized organic growth of approximately 10% for 2026 [26] - The company anticipates continued healthy patient utilization and strong demand for its platform, which is expected to insulate it from reimbursement rate pressures [26][66] Other Important Information - The company expects to realize over 90% of committed cost synergies from the Iodine acquisition in fiscal 2026 [11][29] - Waystar's commercial model aligns with consumption, directly matching how value is created in the revenue cycle [15] Q&A Session Summary Question: Customer appetite for AI integration - Management noted that most clients prefer to integrate AI capabilities into their existing systems rather than build their own, highlighting the importance of a trusted partner [41] Question: Incremental revenue opportunities from new AI agents - New AI agents are expected to provide both incremental revenue opportunities and enhance the existing AI offerings, contributing to client retention and value [43][44] Question: Impact of Iodine on margins and cost centers - The increase in G&A, R&D, and SG&A costs is attributed to the full quarter contribution from Iodine, with expectations for continued margin improvement through cost synergies [48][49] Question: AI market growth in healthcare - Management sees significant opportunities in AI within healthcare, emphasizing the need for secure, scalable, and accurate solutions [60][62] Question: Patient healthcare utilization assumptions - The company expects patient utilization to remain healthy, projecting growth above the historical baseline of 1%-2% [66] Question: Trends in patient deductible timelines - Management observed a decrease in patient volumes as patients hit their deductibles, but this was offset by growth in provider solutions [70][71] Question: Competitive landscape and ROI - Management highlighted robust win rates and the importance of a platform approach, which is increasingly preferred by clients over point solutions [83][84]

Financial Data and Key Metrics Changes - Q4 revenue reached $304 million, growing 24% year-over-year and 12% organically [6][20] - Full year revenue increased 17% year-over-year to $1.1 billion, with organic growth of 13% [20] - Adjusted EBITDA for Q4 was $129 million, up 29% year-over-year, with a margin of 42.5% [9][24] - Unlevered free cash flow was $80 million in Q4 and $365 million for the full year, converting 79% of adjusted EBITDA to unlevered free cash flow [25] Business Line Data and Key Metrics Changes - Subscription revenue for Q4 was $168 million, increasing 38% year-over-year and 25% sequentially, representing 55% of total revenue [23] - Volume-based revenue for Q4 was $134 million, up 11% year-over-year, with steady double-digit growth from both provider solution transactions and patient payment dollars [24] - The number of clients generating more than $100,000 of trailing twelve-month revenue increased by 85 in Q4, totaling 1,391 clients [21] Market Data and Key Metrics Changes - Waystar added 85 clients with trailing twelve-month spend above $100,000, reflecting strong demand and competitive momentum [7] - The company achieved a Net Revenue Retention rate of 112% and a Gross Revenue Retention rate of 97% [8][22] Company Strategy and Development Direction - The acquisition of Iodine Software expanded Waystar's addressable market and strengthened its competitive position [5] - The company aims to lead in AI-powered revenue cycle automation, with approximately 50% of its solutions leveraging AI [12] - Waystar's strategy focuses on delivering a unified financial and clinical platform to enhance operational efficiency and client value [10][19] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the durability of the business model and the ability to sustain profitable growth [6] - The company anticipates revenue growth of $1.274 billion to $1.294 billion for 2026, representing 17% year-over-year growth [26] - Management expects continued healthy utilization of the healthcare system by patients throughout 2026 [26][65] Other Important Information - Waystar's platform is designed to integrate AI capabilities seamlessly, enhancing operational efficiency and client trust [39][61] - The company is focused on maintaining a leverage ratio at or below 3x and plans to continue deleveraging in line with historical rates [25] Q&A Session Summary Question: What is the appetite of customers to use LLMs versus buying from Waystar? - Management noted that most clients prefer to integrate AI capabilities into their existing systems rather than developing them independently due to a lack of engineering talent [39] Question: How do new AI agents impact revenue opportunities? - New AI capabilities will create both incremental revenue opportunities and enhance existing software modules, driving retention and elongation of client relationships [42] Question: What are the implications of increased G&A and R&D costs? - The increase is largely due to the inclusion of Iodine, and management expects to find additional opportunities for cost savings while focusing on long-term revenue growth [46][48] Question: How does Waystar's ROI compare to competitors? - Management emphasized that Waystar's ROI is compelling, supported by strong win rates and the benefits of a platform approach [81] Question: What is the outlook for AI market growth in healthcare? - Management believes the AI opportunity in healthcare is significant, with a focus on delivering secure, scalable, and accurate solutions [58][61]

Summary of Waystar Holding Conference Call Industry Overview - The healthcare industry is facing challenges such as margin pressures, staffing shortages, and shifting policy landscapes, prompting a need for smarter operations and improved financial health [1][5] - The focus is on transforming healthcare payments through AI-powered solutions, with Waystar leading this transformation [1][2] Core Company Insights - **Waystar Altitude AI**: A comprehensive set of AI capabilities designed to enhance efficiency and accuracy in healthcare revenue cycles, eliminating manual processes and accelerating reimbursements [2][6] - **Transaction Data**: Waystar processes over 6 billion transactions and $1.8 trillion in gross claims annually, leveraging this data for smarter automation and financial outcomes [3][4] - **Provider Sentiment**: A Forrester study indicates that 82% of provider organizations consider AI essential for revenue cycle operations, with nearly 60% planning to increase investment in AI [5] Key Innovations and Impact - **Financial Clearance**: Waystar Altitude AI significantly reduces denials and accelerates reimbursement, achieving up to 90% auto-approval on prior authorizations [9] - **Patient Financial Care**: Digital-first billing solutions lead to a 17.5% reduction in statement costs and up to a 20% increase in patient revenue [10] - **Revenue Capture**: The platform helps recover an average of over $3 million in additional annual revenue for clients [11] - **Denial Management**: Automated appeals powered by AI have led to a significant increase in denial overturn rates and recovery of $33 million in revenue for early adopters [12][35] Operational Efficiency - **Time Savings**: For mid-size health systems, the time to manage claim edits has decreased from 133 hours to under 6 hours, representing a 95% time savings [21] - **Prior Authorization**: The expansion of Authorization Manager has resulted in over 90% touchless approvals, significantly reducing the time for authorization processes [26][27] Financial Transparency and Patient Experience - **Patient Wallet**: The Waystar Patient Wallet provides accurate upfront estimates and self-service payment options, increasing pre-payments from 17% to 40% [42] - **Real-Time Monitoring**: Future capabilities will include real-time visibility into payment terminal health, ensuring seamless transactions and uninterrupted care [45] Security and Trust - Waystar emphasizes a robust cybersecurity framework to protect data and operations, being recognized as a trusted vendor in the healthcare sector [52] Conclusion - Waystar is committed to transforming healthcare payments through innovative AI solutions, enhancing operational efficiency, financial performance, and patient experience while maintaining a strong focus on security and trust [53][54]

Financial Data and Key Metrics Changes - Revenue for Q2 2025 reached $271 million, representing a 15% year-over-year growth with an adjusted EBITDA margin of 42% [11][26] - Adjusted EBITDA increased by 20% year-over-year to $113 million, driven by revenue growth and a shift to higher-margin provider solutions [28] - The company raised its full-year revenue guidance to a range of $1.03 billion to $1.042 billion, reflecting a 10% year-over-year growth [30] Business Line Data and Key Metrics Changes - Subscription revenue increased by 17% year-over-year to $131 million, while volume-based revenue grew by 14% year-over-year to $138 million [27] - The number of clients generating more than $100,000 in trailing twelve-month revenue increased by 14% year-over-year to 1,268 [17] Market Data and Key Metrics Changes - The company noted a strong demand for its AI-powered software platform as providers face margin pressures and workforce shortages [11][12] - Waystar's net revenue retention rate was 115%, benefiting from rapid onboarding of clients affected by a competitor's cyber event [26] Company Strategy and Development Direction - The acquisition of Iodine Software is expected to expand Waystar's total addressable market by over 15% and enhance its product roadmap [8][9] - Waystar aims to lead in automating the revenue cycle and maximizing reimbursement for healthcare providers [10][22] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's resilience against potential Medicaid funding cuts, estimating less than a 1% revenue impact from a hypothetical 15% reduction in Medicaid funding [13][87] - The company is optimistic about the demand environment, citing strong provider interest in efficiency and technology adoption [54] Other Important Information - Waystar was recognized as the best overall healthcare payments solution provider by MedTech Breakthrough [23] - The company added two new independent board members to strengthen its governance [24] Q&A Session Summary Question: Impact of client migration post-cyber attack on revenue - Management indicated that the year-over-year benefit from client migration has normalized, and there were no notable impacts in Q2 [34][35] Question: Recurring nature of volume-based revenue from large clients - Management expects that volume-based revenue from newly onboarded large clients will become recurring as contracts mature [42][46] Question: Drivers behind the sequential increase in subscription revenue - Management attributed the growth to strong performance in provider solutions and continued adoption of subscription services [50][57] Question: Volume growth and digital payment penetration - Management noted that higher utilization and digital payment solutions are driving volume growth, with a good mix from both patient payment and provider solutions [60][64] Question: AI's impact on client demand and revenue - Management highlighted that AI is embedded in their solutions, significantly improving claim processing and denial prevention [72][73] Question: Analysis of Medicaid funding changes and their impact - Management reassured that the diverse client base insulates the company from significant impacts due to funding changes, with alternative solutions available to providers [84][87] Question: Mid-cycle opportunities and AI's role - Management emphasized the potential of AI in mid-cycle revenue cycle management, particularly through the acquisition of Iodine [101][102]

Financial Data and Key Metrics Changes - Revenue for Q2 2025 reached $271 million, representing a 15% year-over-year growth with an adjusted EBITDA margin of 42% [10][24] - Adjusted EBITDA for Q2 2025 was $113 million, an increase of 20% year-over-year, driven by revenue growth and a shift to higher margin provider solutions [26][30] - The company raised its full-year revenue guidance to a range of $1.03 billion to $1.042 billion, reflecting a 10% year-over-year growth [29] Business Line Data and Key Metrics Changes - Subscription revenue increased to $131 million, up 17% year-over-year, while volume-based revenue reached $138 million, a 14% increase year-over-year [25] - The number of clients generating more than $100,000 in trailing twelve-month revenue increased to 1,268, a 14% year-over-year growth [15] Market Data and Key Metrics Changes - The company noted a strong demand for its AI-powered software platform as providers face margin pressures and workforce shortages [10][12] - Waystar's net revenue retention rate was 115%, benefiting from rapid onboarding of clients affected by a competitor's cyber event [24] Company Strategy and Development Direction - The acquisition of Iodine Software is expected to expand Waystar's total addressable market by over 15% and enhance its product roadmap [6][7] - Waystar aims to lead in the revenue cycle management space by leveraging AI to improve efficiency and reduce administrative burdens for healthcare providers [20][22] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's resilience against potential Medicaid funding cuts, estimating less than a 1% impact on revenue from a hypothetical 15% reduction in Medicaid funding [12][85] - The demand environment remains robust, with providers prioritizing technology that enhances efficiency and cash flow [51][52] Other Important Information - Waystar was recognized as the best overall healthcare payments solution provider by MedTech Breakthrough and named one of the U.S. News Best Companies to Work For [22][23] - The company has established a strong governance structure with the addition of two new independent board members [23] Q&A Session Summary Question: Impact of client migration post-cyber attack on Q2 revenue - Management indicated that the year-over-year benefit from client migration had normalized by Q2, with no significant impact noted [34][36] Question: Recurring nature of volume-based revenue from large clients - Management expects that volume-based revenue from newly onboarded large clients will transition to subscription revenue as contracts mature [45][46] Question: Drivers behind the sequential increase in subscription revenue - The increase in subscription revenue was attributed to strong performance in provider solutions, which comprise a significant portion of total revenue [50][55] Question: Volume growth and digital payment penetration - Management noted that higher utilization in the healthcare system and the adoption of digital payment solutions contributed to volume growth, with a good mix from both patient payment and provider solutions [58][61] Question: Competitive landscape and client demand - Management reported strong win rates against competitors and noted an increase in client demand for AI-driven solutions [106]